Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Swati Garg

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
Archives of Pathology & Laboratory Medicine|May 31, 2017
Integration of Technical, Bioinformatic, and Variant Assessment Approaches in the Validation of a Targeted Next-Generation Sequencing Panel for Myeloid MalignanciesMariam Thomas, Mahadeo A Sukhai, Tong Zhang, et al.
Gynecologic Oncology Reports|March 15, 2021
Can <i>TP53</i> variant negative be high-grade serous ovarian carcinoma? A case seriesLawrence Kasherman, Swati Garg, Nairi Tchrakian, et al.
Cold Spring Harbor Molecular Case Studies|December 15, 2019
Heterogeneous alteration of the ERBB3-MYC axis associated with MEK inhibitor resistance in a <i>KRAS</i>-mutated low-grade serous ovarian cancer patientIlaria Colombo, Swati Garg, Arnavaz Danesh, et al.
Disease Models & Mechanisms|September 8, 2019
A small bioactive glycoside inhibits epsilon toxin and prevents cell deathAbhishek Shivappagowdar, Soumya Pati, Chintam Narayana, et al.
Scientific Reports|February 26, 2021
Interaction of Plasmodium falciparum apicortin with α- and β-tubulin is critical for parasite growth and survivalMalabika Chakrabarti, Nishant Joshi, Geeta Kumari, et al.
Molecular and Cellular Biochemistry|November 4, 2018
Integrative natural medicine inspired graphene nanovehicle-benzoxazine derivatives as potent therapy for cancerNaveen Kumar, Nisha Yadav, Nagarjuna Amarnath, et al.
International Immunopharmacology|February 21, 2025
Evaluation of Immunopharmacological efficacy of live Leishmania donovani overexpressing Ld_ζ1<sub>domain</sub> for protection against experimental human visceral LeishmaniasisRuby Bansal, Sadat Shafi, Prachi Garg, et al.
Molecular Therapy. Oncology|July 13, 2026
A novel combination approach targeting P300 and DNA-PK exploits epigenetic dependencies in acute myeloid leukemiaSrinivas Vinod Saladi, Swati Garg, Ellen L Weisberg, et al.
Haematologica|August 3, 2023
Hypomethylating agent decitabine sensitizes diffuse large B-cell lymphoma to venetoclaxFen Zhu, Jennifer L Crombie, Wei Ni, et al.
Cancers|April 13, 2024
Synergy between BRD9- and IKZF3-Targeting as a Therapeutic Strategy for Multiple MyelomaBasudev Chowdhury, Swati Garg, Wei Ni, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
Archives of Pathology & Laboratory Medicine|May 31, 2017
Integration of Technical, Bioinformatic, and Variant Assessment Approaches in the Validation of a Targeted Next-Generation Sequencing Panel for Myeloid MalignanciesMariam Thomas, Mahadeo A Sukhai, Tong Zhang, et al.
Gynecologic Oncology Reports|March 15, 2021
Can <i>TP53</i> variant negative be high-grade serous ovarian carcinoma? A case seriesLawrence Kasherman, Swati Garg, Nairi Tchrakian, et al.
Cold Spring Harbor Molecular Case Studies|December 15, 2019
Heterogeneous alteration of the ERBB3-MYC axis associated with MEK inhibitor resistance in a <i>KRAS</i>-mutated low-grade serous ovarian cancer patientIlaria Colombo, Swati Garg, Arnavaz Danesh, et al.
Disease Models & Mechanisms|September 8, 2019
A small bioactive glycoside inhibits epsilon toxin and prevents cell deathAbhishek Shivappagowdar, Soumya Pati, Chintam Narayana, et al.
Scientific Reports|February 26, 2021
Interaction of Plasmodium falciparum apicortin with α- and β-tubulin is critical for parasite growth and survivalMalabika Chakrabarti, Nishant Joshi, Geeta Kumari, et al.
Molecular and Cellular Biochemistry|November 4, 2018
Integrative natural medicine inspired graphene nanovehicle-benzoxazine derivatives as potent therapy for cancerNaveen Kumar, Nisha Yadav, Nagarjuna Amarnath, et al.
International Immunopharmacology|February 21, 2025
Evaluation of Immunopharmacological efficacy of live Leishmania donovani overexpressing Ld_ζ1<sub>domain</sub> for protection against experimental human visceral LeishmaniasisRuby Bansal, Sadat Shafi, Prachi Garg, et al.
Molecular Therapy. Oncology|July 13, 2026
A novel combination approach targeting P300 and DNA-PK exploits epigenetic dependencies in acute myeloid leukemiaSrinivas Vinod Saladi, Swati Garg, Ellen L Weisberg, et al.
Haematologica|August 3, 2023
Hypomethylating agent decitabine sensitizes diffuse large B-cell lymphoma to venetoclaxFen Zhu, Jennifer L Crombie, Wei Ni, et al.
Cancers|April 13, 2024
Synergy between BRD9- and IKZF3-Targeting as a Therapeutic Strategy for Multiple MyelomaBasudev Chowdhury, Swati Garg, Wei Ni, et al.
Pageof 10